Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center.
Itelman E, Wasserstrum Y, Segev A, Avaky C, Negru L, Cohen D, Turpashvili N, Anani S, Zilber E, Lasman N, Athamna A, Segal O, Halevy T, Sabiner Y, Donin Y, Abraham L, Berdugo E, Zarka A, Greidinger D, Agbaria M, Kitany N, Katorza E, Shenhav-Saltzman G, Segal G. Itelman E, et al. Among authors: agbaria m. Isr Med Assoc J. 2020 May;22(5):271-274. Isr Med Assoc J. 2020. PMID: 32378815 Free article.
Frailty and Sarcopenia Assessment upon HospitalAdmission to Internal Medicine Predicts Length ofHospital Stay and Re-Admission: A ProspectiveStudy of 980 Patients.
Anani S, Goldhaber G, Brom A, Lasman N, Turpashvili N, Shenhav-Saltzman G, Avaky C, Negru L, Agbaria M, Ariam S, Portal D, Wasserstrum Y, Segal G. Anani S, et al. Among authors: agbaria m. J Clin Med. 2020 Aug 17;9(8):2659. doi: 10.3390/jcm9082659. J Clin Med. 2020. PMID: 32824484 Free PMC article.
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system.
Reus P, Guthmann H, Uhlig N, Agbaria M, Issmail L, Eberlein V, Nordling-David MM, Jbara-Agbaria D, Ciesek S, Bojkova D, Cinatl J, Burger-Kentischer A, Rupp S, Zaliani A, Grunwald T, Gribbon P, Kannt A, Golomb G. Reus P, et al. Among authors: agbaria m. J Control Release. 2023 Dec;364:654-671. doi: 10.1016/j.jconrel.2023.10.050. Epub 2023 Nov 16. J Control Release. 2023. PMID: 37939853 Free article.
Non-invasive method for assessment of inflammation.
Fine I, Kaminsky A, Shenkman L, Agbaria M. Fine I, et al. Among authors: agbaria m. Biomed Opt Express. 2023 Aug 25;14(9):4901-4913. doi: 10.1364/BOE.494637. eCollection 2023 Sep 1. Biomed Opt Express. 2023. PMID: 37791253 Free PMC article.
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes.
Hirsch S, Hinden L, Naim MB, Baraghithy S, Permyakova A, Azar S, Nasser T, Portnoy E, Agbaria M, Nemirovski A, Golomb G, Tam J. Hirsch S, et al. Among authors: agbaria m. J Control Release. 2023 Jan;353:254-269. doi: 10.1016/j.jconrel.2022.11.040. Epub 2022 Nov 30. J Control Release. 2023. PMID: 36442615 Free PMC article.
22 results